Ectopic paraesophageal mediastinal parathyroid adenoma, a rare cause of acute pancreatitis
© Foroulis et al; licensee BioMed Central Ltd. 2004
Received: 21 May 2004
Accepted: 30 November 2004
Published: 30 November 2004
The manifestation of primary hyperparathyroidism with acute pancreatitis is a rare event. Ectopic paraesophageal parathyroid adenomas account for about 5%–10% of primary hyperparathyroidism and surgical resection results in cure of the disease.
A 71-year-old woman was presented with acute pancreatitis and hypercalcaemia. During the investigation of hypercalcemia, a paraesophageal ectopic parathyroid mass was detected by computerized tomography (CT) scan and 99mTc sestamibi scintigraphy. The tumor was resected via a cervical collar incision and calcium and parathormone tumor levels returned to normal within 48 hours.
Acute pancreatitis associated with hypercalcaemia should pose the suspicion of primary hyperparathyroidism. Accurate preoperative localization of an ectopic parathyroid adenoma, by using the combination of 99mTc sestamibi scintigraphy and CT scan of the neck and chest allows successful surgical treatment.
Acute pancreatitis occurring secondary to hypercalcemia is rare. Most of the time adenomas are located in the neck. However, in 10–20% cases the parathyroid adenomas are found to be located within the mediastinum [1, 2]. The lower parathyroid glands develop from the third pharyngeal pouch in close association with the thymus and they may migrate along with the thymus during development. As a result they may be found commonly within the anterosuperior mediastinum. On the other hand, the superior parathyroid glands are not associated with the thymus and may even be located in the posterior mediastinum [1–3]. Paraesophageal or retroesophageal parathyroid tumors arise from superior parathyroid glands, have normal blood supply from a branch of the inferior thyroid artery and are not embryologically considered ectopic [1–3].
We present a case of paraesophageal parathyroid adenoma clinically presenting as acute pancreatitis and successfully managed surgically by the collaboration of thoracic and general surgeons, via a cervical incision.
Recurrent episodes of acute pancreatitis secondary to hypercalcemia are an uncommon presentation of primary hyperparathyroidism [4–7]. Acute pancreatitis is reported to be associated with primary hyperparathyroidism in 1% – 8% of cases in some large published series [4–7]. Sporadically reported cases of acute pancreatitis induced by primary hyperparathyroidism, in both the recent and past medical literature, suggest that the relationship between the two clinical conditions is not incidental [8–15]. Carnaille et al found significantly elevated serum calcium levels to be of major importance in the development of pancreatitis in patients with primary hyperparathyroidism .
Increased levels of serum calcium at the first episode of acute pancreatitis should pose the suspicion of primary hyperparathyroidism. In patients with a history of cholecystectomy (as in the presented case), where the main cause of an episode of acute pancreatitis is bile duct lithiasis, the diagnosis could be missed if serum calcium levels ranged within normal values. The main causes of primary hyperparathyroidism are single or double parathyroid adenoma (80%), hyperplasia of all four or more existing parathyroid glands (15–20%) and rarely cancer of the parathyroid gland (2%) [1, 2, 16].
Richards et al reported 5%–10% of the parathyroid glands to be located in the posterior mediastinum, 20% are found substernally within the thymic tissue in the anterior mediastinum (1–2%) while 1% of the glands are located in the carotid sheath and 5% into the thyroid gland.  Other rare sites of ectopic parathyroid tissue are the vagus nerve sheath, the thyrothymic ligament and the pericardium . By reviewing 112 patients who underwent re-operation for primary hyperparathyroidism, Wang found 39% of missing adenomas to be located in the retrotracheal space . Parathyroid glands, are now found with increasing frequency in the visceral compartment of the mediastinum (aortopulmonary window and right pulmonary artery, close to the tracheal bifurcation), because of the improvement of the imaging techniques (99mTc sestamibi scintigraphy). The frequency of this occurrence at the moment is uncertain .
Many investigators advocate the need for the concordance of at least two diagnostic modalities before surgical excision. The combination of 99mTc sestamibi scintigraphy and CT scan of the chest and neck gives important information to proceed with surgery and to minimize the risk of re-operation for recurrent hyperparathyroidism in the future [3, 16, 18, 19]. The combination of both techniques had 100% sensitivity and 97.4% positive predictive value for the detection of the cause of primary hyperparathyroidism . The spectrum of diseases demonstrated with 99mTc scintigraphy includes eutopic parathyroid disease, ectopic parathyroid disease, solitary, double or multiple parathyroid adenoma, cystic adenoma, lipoadenoma, multiple endocrine neoplasia, entities with atypical washout and non-parathyroid entities that take up 99mTc sestamibi (normal and pathologic cervical, supraclavicular, axillary lymph nodes, hyperplastic thymus, focal soft tissue uptake from a sarcoid or carcinoid tumor) . The addition of early lateral views to the conventional 99mTc sestamibi scintigraphy gives more information to the surgeon, concerning the depth of the lesion in atypical sites .
CT scan with intravenously injected contrast material has a low overall sensitivity of 45%–55% in primary hyperparathyroidism, but it is helpful mainly in the detection of ectopic mediastinal parathyroid adenomas [2, 3]. Magnetic resonance imaging (MRI) of the neck and chest has a sensitivity of about 80%. The sensitivity of MRI is higher for the detection of ectopic mediastinal parathyroid adenomas (88%) . Selective angiography combined with venous parathyroid hormone sampling has sensitivity between 60% and 85%. However, selective angiography is an aggressive and complicated approach and it is not advised as the initial approach in primary hyperaparathyroidism [2, 3]. Single photon-emission computed tomographic (SPECT) sestamibi scintigraphy of the neck and thorax has the capability of three-dimensional assessment and it is considered to be the optimal method for the evaluation of parathyroid disease, especially that of mediastinum for ectopic parathyroid glands [21–24]. Fusion of sestamibi SPECT images onto the CT images using a software package, as described by Patrick et al, gives excellent information on the exact localization of ectopic parathyroid tissue . FDG-PET was found to have higher sensitivity than the sestamibi-SPECT in a prospective study by Neumann et al for preoperative detection and localization of parathyroid adenomas; high cost and limited availability of the scanners restrict its use as first-line examination in primary hyperparathyroidism .
Paraesophageal mediastinal adenomas are resected via a cervical incision in the majority of cases [1, 2, 16, 26]. By retracting the thyroid gland and trachea to the opposite side, a finger can be inserted into the pretracheal space, even down to the mediastinum, to palpate the tumor. If the tumor is localized by finger palpation, it is easy to mobilize by blunt (finger) dissection and to expose it into the operating field. The vascular pedicle is the only structure that needs to be ligated. When an ectopic cervical or paraesophageal parathyroid adenoma is detected preoperatively by imaging studies, intraoperative frozen section of the adenoma and of a homolateral parathyroid gland, on which normal parathyroid tissue will be confirmed, precludes diffuse parathyroid hyperplasia. A targeted operation can then be chosen, which has the advantage of minimizing the time of operation and avoiding serious hypocalcemia in the immediate postoperative period. 
An ectopic paraesophageal parathyroid adenoma may be manifested with an episode of acute pancreatitis. Preoperative investigation for exact localization of an adenoma should include two imaging studies, preferably Tc-99m sestamibi scintigraphy or sestamibi-SPECT scintigraphy of the neck and chest and CT scan of the neck and chest. Resection of an ectopic paraesophageal adenoma is easily accomplished via a cervical incision and blunt mobilization of the tumor.
CNF has made contribution to the conception, design and drafting of the article, was involved in the critical revision of the article.
S R has made contribution to the conception, design and drafting of the article.
C L has made contribution to the conception and design of the article.
D K has made contribution to the conception and design of the article.
G K has made contribution to the conception and design of the article, was involved in the critical revision of the article.
AL has made contribution to the conception and design of the article, was involved in the critical revision of the article.
All the authors have read and approved the final version of the manuscript.
Written consent was obtained from the relative of the patient for publication of the case.
- Ewing P, Hardy JD: The mediastinum. Glenn's Thoracic and Cardiovascular Surgery. Edited by: Baue AE, Geha AS, Hammond GL, Laks H, Naunheim KS. 1991, Connecticut: Appleton and Lange, 1: 569-594. 5Google Scholar
- Richards ML, Bondeson AG, Thompson NW: Mediastinal parathyroid adenomas and carcinomas. General Thoracic Surgery. Edited by: Shields TW, LoCicero III J, Ponn RB. 2000, Philadelphia: Lippincot Williams and Willkins, 2: 2383-2390. 5Google Scholar
- Nguyen BD: Parathyroid imaging with Tc-99m sestamibi planar and SPECT scintigraphy. Radiographics. 1999, 19: 601-614.View ArticlePubMedGoogle Scholar
- Agarwal A, George RK, Gupta SK, Mishra SK: Pancreatitis in patients with primary hyperparathyroidism. Indian J Gastroenterol. 2003, 22: 224-225.PubMedGoogle Scholar
- Shepherd JJ: Hyperparathyroidism presenting as pancreatitis or complicated by postoperative pancreatitis. Aust N Z J Surg. 1996, 66: 85-87.View ArticlePubMedGoogle Scholar
- Koppelberg T, Bartsch D, Printz H, Hasse C, Rothmund M: Pancreatitis in primary hyperparathyroidism (pHPT) is a complication of advanced pHPT. Dtsch Med Wochenschr. 1994, 119: 719-724.View ArticlePubMedGoogle Scholar
- Carnaille B, Oudar C, Pattou F, Combamale F, Rocha J, Proye C: Pancreatitis and primary hyperparathyroidism: forty cases. Aust N Z J Surg. 1998, 68: 117-119.View ArticlePubMedGoogle Scholar
- Husova L, Senkyrik M, Lata J, Hrbkova V, Husa P, Dolina J, Podral M, Ourednicek P: Acute pancreatitis as the road to diagnosis of primary hyperparathyroidism. Vnitr Lek. 2000, 46: 724-727.PubMedGoogle Scholar
- Boneschi M, Erba M, Beretta L, Miani S, Bortolani EM: Primary hyperparathyroidism and acute pancreatitis. A rare clinical association. Minerva Chir. 1999, 54: 451-454.PubMedGoogle Scholar
- Shimizu H, Kodama A: Hypercalcemia and pancreatitis as a first symptom of primary hyperparathyroidism adenoma: a case report. J Laryngol Otol. 1996, 110: 602-603.PubMedGoogle Scholar
- Nieves-Rivera F, Gonzalez-Pijem L: Primary hyperparathyroidism: an unusual cause of pancreatitis in adolescence. P R Health Sci J. 1995, 14: 233-236.PubMedGoogle Scholar
- Ginn DR, Gate J, Tootle K, Salazar S, Watson S: Parathyroid adenoma manifested as pancreatitis and polyuria. South Med J. 1991, 61: 396-398.Google Scholar
- Maddern GJ, Fielding GA, Knaus JP, Zinng E, Blumgart LH: A case of severe pancreatitis with parathyroid adenoma. Aust N Z J Surg. 1991, 84: 1023-1025.Google Scholar
- Abdullah M: Pancreatitis in primary hyperparathyroidism. Med J Malaysia. 2003, 58: 600-603.PubMedGoogle Scholar
- Meldahl I, Ljungstrom KG, Wickerts CJ, Von Sigers K: Fulminant acute pancreatitis caused by a large parathyroid adenoma. Hyperparathyroidism was diagnosed after 5 years. Lakartidningen. 1999, 26: 2603-2606.Google Scholar
- Fraker DL: Update on the management of parathyroid tumors. Curr Opin Oncol. 2000, 12: 41-48. 10.1097/00001622-200001000-00007.View ArticlePubMedGoogle Scholar
- Wang CA: Parathyroid reexploration. A clinical and pathological study of 112 cases. Ann Surg. 1977, 186: 140-145.PubMed CentralView ArticlePubMedGoogle Scholar
- Lumachi F, Tregnaghi A, Zucchetta P, Marzola MC, Cecchin D, Marchesi P, Fallo F, Bui F: Technetium-99m sestamibi scintigraphy and helical CT together in patients with primary hyperparathyroidism: a prospective clinical study. Br J Radiol. 2004, 77: 100-103. 10.1259/bjr/44399050.View ArticlePubMedGoogle Scholar
- Patrick N, Lenzo NP, McCarthy MC, Thompson I, Leedman PJ: Ectopic parathyroid adenoma localized with sestamibi SPECT and image-fused computed tomography. MJA. 2003, 179: 485-487.Google Scholar
- Serrano Vicente J, Rayo Madrid JL, Luengo Perez LM, Diaz Perez de Madrid J: 99m-Tc sestamibi scintigraphy in primary hyperparathyroidism. Importance of lateral projections using a pin-hole collimator. Rev Esp Med Nucl. 2003, 22: 403-409. 10.1157/13052914.View ArticlePubMedGoogle Scholar
- Perez-Monte JE, Brown ML, Shah AN, Ranger NT, Watson CG, Carty SA, Clarke MR: Parathyroid adenomas: accurate detection and localization with Tc-99m sestamibi SPECT. Radiology. 1996, 201: 85-91.View ArticlePubMedGoogle Scholar
- Casas AT, Burke GJ, mansberger AR, Wei JP: Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperaparathyroidism. Am Surg. 1994, 60: 12-17.PubMedGoogle Scholar
- Udelsman R: Parathyroid imaging: the myth and the reality. Radiology. 1996, 201: 317-318.View ArticlePubMedGoogle Scholar
- Mariani G, Gulec SA, Rubello D, Boni G, Puccini M, Pelizzo MR, Manca G, Casara D, Sotti G, Erba P, Volteranni D, Giuliano AE: Preoperative localization and radioguided parathyroid surgery. J Nucl Med. 2003, 44: 1443-1458.PubMedGoogle Scholar
- Neumann DR, Esselstyn CB, MacIntyre WJ, Go RT, Obuchowski NA, Chen EQ, Licata AA: Comparison of FDG-PET and sestamibi-SPECT in primary hyperparathyroidism. J Nucl Med. 1996, 37: 1809-1815.PubMedGoogle Scholar
- Barclay L: Unilateral approach for parathyroid surgery. Ann Surg. 2002, 236: 543-551. 10.1097/00000658-200211000-00001.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.